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The first phase in the management of mental illnesses requires an intimate 
understanding of the thorough side effects of the medications prescribed. The treatment 
of antipsychotics involves a unique approach. New technological shifts in the field of 
anti-psychotic medications have been revolutionized. While most anti-psychotic 
medications are capable of battling psychosis, the effects vary from medication to 
medication. The susceptibility of akathisia has significant consequences. Akathisia can be 
easily overlooked and passed off as irritability leading to misdiagnosis.  
The purpose of the Doctor of Nursing Project (DNP) was to bring awareness to 
akathisia and the Barnes Akathisia Rating Scale (BARS). Patients taking anti-psychotics 
need an accurate tool to measure their baseline prior to starting anti-psychotics and an 
accurate to measure the side effects of anti-psychotics during treatment. The BARS scale 
is the solution to accurately measure akathisia symptoms.  
The DNP project was conducted in an outpatient clinic in southern Mississippi. 
Four hundred thirty-six (436) patients were seen within a 30-day time frame. Of those 
436 patients 27 patients presented with symptoms of akathisia. The healthcare providers 
at this clinic documented akathisia's symptoms using a narrative note or the Abnormal 
Involuntary Movement Scale (AIMS). This scale can mask akathisia symptoms because it 
does not distinguish between akathisia and tardive dyskinesia. The two side effects have 
very different treatments. It is important to rate the level of severity on abnormal 
movement-specific scales. The BARS Scale measures akathisia exclusively.  
Participants in the DNP project were given a pre-test, education, and a post-test. 
The pre-test tested the knowledge of participants' awareness of akathisia, the BARS 
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scale, and how they currently document akathisia. The pre-test revealed that 60% of 
participants see akathisia on a weekly basis. Most participants documenting akathisia 
using a narrative note, while 20% used the AIMS scale to document akathisia. The 
education was given in a form of a PowerPoint®. The post-test was scenario-based 
patients and required the use of the BARS scale to rate the level of the severity of 
akathisia each patient presented with. Participants’ post-tests were compared. The post-
test revealed 80% of the participants answered the scenario-based questions similarly. 
The post-test proves that the BARS scale validity to measure akathisia.  
The findings from this DNP project indicate that there is a need for an akathisia 
scale in an outpatient clinical setting. Research revealed that patients taking anti-
psychotics are distressed due to their akathisia. First episode akathisia patient’s 
experience thoughts of suicide (Salem, 2017). Patients usually stop taking their 
medications due to having thoughts of suicide induced by akathisia. The distress caused 
by the side effects of antipsychotics needs to be addressed. The BARS scale is easy to use 
tool to measure the baseline of akathisia symptoms and is a tool that can be used 
throughout the treatment of antipsychotic use. The BARS scale aids in the early detection 
and treatment of akathisia. Early treatment of akathisia lessens the patients’ feelings of 
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CHAPTER I - INTRODUCTION 
While working many years in mental health when reviewing charts, it appeared 
routine to see that each patient had a history and physical exam along with an AIMS 
(Abnormal Involuntary Movement Scale) scale assessment. AIMS scale exclusively 
favors the measures for tardive dyskinesia. Tardive dyskinesia is a condition that affects 
the nervous system caused by the long-term use of neuroleptic/anti-psychotic 
medications. Throughout the years of caring for mental health patients’ tardive dyskinesia 
was rarely seen in acute care settings or outpatient settings. Tardive dyskinesia was 
mostly seen in long-term care mental health facilities like a forensic hospital. Akathisia, 
however, was a more common side effect of antipsychotic use that was seen often. 
Akathisia is a feeling of muscle quivering, restlessness, and inability to sit still. Akathisia 
can be very distressing to the patient and can be misdiagnosed and passed off as agitation 
(Hirose, 2003). There should be a scale incorporated into the initial mental health 
assessment to measure the baseline symptoms of akathisia. The BARS (Barnes Akathisia 
Rating Scale) scale measures the severity of akathisia symptoms. This scale aids in the 
early detection and treatment of akathisia and rids the patient of distress, potential 
noncompliance with medication, and declining health.  
Background and Significance 
Akathisia is a common side effect of antipsychotics that can go unrecognized to 
the untrained eye and can be overlooked by a trained healthcare professional. It is 
important to be direct when asking patients questions about akathisia. Patients often feel 
inner restlessness or a sudden urge to move. They may be seen squirming or fidgeting 
intermittently. It is important to educate the patient on these side effects and follow up 
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with an akathisia questionnaire each visit. PHMNP and Psychiatrists can easily overlook 
akathisia due to a lack of objective findings. 
The BARS scale was originally created thirty years ago and are one of the most 
underutilized akathisia scales created. Its’ validity and reliability have been established 
worldwide. The Turkish created a version of the BARS scale to help with the diagnosis of 
akathisia and to provide an objective tool for researching akathisia (Bayram et al., 2017). 
The Turkish used five physicians and forty patients with schizophrenia who were taking 
anti-psychotics for their study. The results shown from each patient were positive for 
akathisia and the study rated the BARS scale as a reliable tool to use to measure akathisia 
(Bayram et al., 2017). 
The AIMS scale is currently used to measure akathisia and tardive dyskinesia. 
The AIMS scale can mask symptoms of akathisia. The AIMS scale particularly favors 
tardive dyskinesia. The numerical value at the end of the AIMS scale does not distinguish 
which abnormal movement is rated. Both abnormal movements are induced by anti-
psychotics but are treated very differently, for this reason, an akathisia scale should be 
used to rate akathisia accurately.  
Problem Statement/Clinical Question (PICOT) 
(P) In mental health patients ages, 18-64 taking antipsychotic medications, 
visiting a mental health clinic setting experiencing akathisia symptoms. (I) does use 
akathisia measuring scale to properly assess and rate the level of severity of akathisia. (C) 
compared to using an AIMS scale which favors tardive dyskinesia. (O) Offer earlier 





This research aims to assess akathisia in a clinical setting. Proper understanding 
of akathisia can lead to recognition, early detection, and treatment of akathisia. The study 
seeks to explain the severity and the issues related to this psychotropic drug-induced 
disorder. To assess the severity of akathisia, the clinician must first be familiar with the 
condition and be familiar with the akathisia scale to accurately measure its presentation. 
This research aims to bring recognition to the Barnes Akathisia Rating Scale (BARS). 
The BARS scale was created in 1989 and was revisited in 2003. This scale is the most 
accurate in comparison to the only other documented scale found to solely measure anti-
psychotic induced akathisia, the Hillside Akathisia Scale (HAS). The BARS scale is very 
useful in systematically assessing patients with akathisia, rating their severity, and 
monitoring their change in symptoms.  
Objective and Expected Outcomes 
The objective outcomes are to teach healthcare providers about the Barnes 
Akathisia Rating Scale and bring awareness to the mental distress akathisia may cause to 
patients. The expected outcomes are to incorporate the Barnes Akathisia Rating Scale 
into the initial mental health assessment and revisit the scale for follow-up visits with 
patients that are taking anti-psychotics.  
Theoretical Framework 
Akathisia can take place days to weeks after the initial start of an anti-psychotic or 
after an increased dose of an anti-psychotic (Salem et al., 2017). Tardive dyskinesia 
usually occurs 1-3 months after the start of treatment (Salem et al., 2017). Currently, 
physicians, nurse practitioners, and physician assistants are conducting AIMS scores on 
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every mental health patient. Since AIMS measures abnormal movements and akathisia is 
considered an abnormal movement, akathisia measurements can be measured on numbers 
5, 6, 8, 9, and 10 of the AIMS scales (Menzies & Farrell, 2002). These numbers on the 
AIMS scale measure extremity movements and global judgments, but in relation to 
tardive dyskinesia, not akathisia. The other questions focus on orofacial movements, 
trunk movements, and dental status which are symptoms are tardive dyskinesia. This 
scoring method does not solely address akathisia and can mask akathisia ratings. 
Akathisia is a more common side effect seen today with the use of multiple second-
generation anti-psychotics (Salem et al., 2017). Patients on more than one second-
generation anti-psychotic had an increase of 34.2% vs 10.9% on experiencing akathisia 
(Salem et al., 2017). The BARS scale would be a more appropriate and more accurate 
approach to measuring akathisia symptoms and tracking the progression of decline in 
symptoms throughout treatment. The BARS scale is a simple solution to capturing 
akathisia symptoms. If akathisia symptoms go unnoticed it can lead to an emergency, 
especially since akathisia is related to increased thoughts of suicide and increased 
thoughts of aggression and violence (Salem et al., 2017). Anti-psychotics tend to cause 
more weight gain and thus contribute to cardiovascular disease in patients with 
schizophrenia. Patients with schizophrenia tend to have heart disease due to poor eating 
habits, sedentary lifestyles, and smoking.  
DNP Essentials 
DNP Essential III, Clinical Scholarship Analytical Methods for Evidence-Based 
Practice details the DNP graduates’ role in assuring accountability of quality care and 
patient safety. This DNP essential allows DNP graduates to facilitate the skills of 
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organization-wide changes that are patient-centered (Spencer, 2019). DNP Essential III 
best describes this project because it supports quality care and patient safety. The 
implementation of the akathisia scale during the initial mental health assessment offers a 
baseline for each patient being started on an anti-psychotic. If the patient has any 
abnormal movement like a tic or tremor before starting an anti-psychotic this scale will 
rate the tremor as such and give a baseline rating as the patient presents before treatment. 
There will be no confusion on the level of severity of akathisia due to taking 
antipsychotic medication. When the patient begins psychotropic treatment, there will data 
to show when the patient's akathisia symptoms started, without giving a false rating or 
narrative. DNP Essential III suggests that the findings of evidence-based practice be used 
to improve healthcare outcomes (Spencer, 2019). The BARS scale will be used to detect 
and treat akathisia at its early stages. Implementing the BARS scale improves patient 
outcomes and decreases the length of time a patient could experience such debilitating 
side effects.  
DNP Essential VI, Interprofessional Collaboration for Improving Patient and 
Population Health Outcomes enforces the need for patient care to be a team-based 
approach. This DNP essential exhibits how thorough effective communication and 
collaboration with patient care and patient outcomes are priority (Spencer, 2019). DNP 
Essential VI relates to this DNP project topic because it references a team-based 
approach. Patients can be cared for by multiple providers or may choose to switch 
providers. In doing so, through electronic charting multiple providers have access to 
patients’ electronic medical records. Electronic charting allows for easy access to the 
patients’ charts. Continuity of care is an important aspect to point out with this project. 
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Through the use of the BARS scale, it allows patient outcomes and improvement of 
akathisia symptoms to be easily transferred. The severity of akathisia last documented on 
the patient can be used as a resource for the level of severity of akathisia in the patient 
viewed by the new clinician. Through collaboration, providers can view the patient's 
progress of treatment with the use of the BARS scale. 
Needs Assessment  
The author conducted a needs assessment at a southern Mississippi behavioral 
health clinic. The clinic was proven to have a need for an akathisia project according to 
the data provided by the clinic’s nurse practitioners. There were 436 patients seen by the 
provider within 30 days. Within the 30-day time frame, 27 of the 436 patients were 
reported to have akathisia symptoms. The patient’s akathisia symptoms were recorded in 
a narrative note or using the AIMS scale. The AIMS scale revealed a numerical value that 
distinguished abnormal movement. The AIMS scale numerical value does not specify 
which abnormal movement is present. The BARS scale would be better in identifying the 
level of severity of akathisia symptoms without being masked by EPS other symptoms.  
Synthesis of Evidence 
Anti-psychotic induced akathisia is a truly relevant topic. Attention was first 
bought to akathisia in 1961 (Turk et al., 2018). The common side effect of akathisia can 
cause a stigmatizing effect on patients leading them to depression, medication 
noncompliance, and potential debilitating psychosis (Bjarke et al., 2020). Suicidality is 
related to akathisia symptoms as well. The supportive text notes that the first episode of 
akathisia patients had an increased risk of possible suicide (Bjarke et al., 2020). 
Abnormal movement symptoms were thought to decrease with the use of second-
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generation antipsychotics (SGA) also known as atypical antipsychotics, but a substantial 
number of patients treated with atypical anti-psychotics still experience akathisia (Bjarke 
et al., 2020).   
There are scales available to measure akathisia. The scales are not utilized to their 
full potential. Most clinicians are not aware that these scales exist. The BARS scale is a 
short but thorough scale that measures akathisia symptoms. This scale is easy to 
incorporate into daily assessments. The AIMS scale used during initial mental health 
assessment does not favor symptoms we see today with the use of atypical anti-
psychotics. Adding the BARS scale would make a huge difference and impact the way 
clinical notes are viewed for patients that present with akathisia symptoms. The BARS 
scale would make comparing akathisia symptoms from a visit to visit easier. If clinicians 
alternated care, the BARS scale would allow transparency of akathisia symptoms from 
the previous visit, making it easier to make changes to medications seamlessly. 
Akathisia and restless leg syndrome share some similarities. Restless leg 
syndrome is characterized by an irritable sensation in the legs that is relieved by 
movement and occurs more often in the late afternoon or evening (Turk et al., 2020). 
Restless and crawling sensations can also be a symptom of akathisia except it would not 
fluctuate like restless leg syndrome (Turk et al., 2020). There are symptoms that persist in 
both disorders that make the two easily confused. The clinician must be able to 
distinguish the two disorders to properly treat the patient. The BARS scale could be 
helpful for use of rating akathisia symptoms and distinguishing the difference between 
akathisia and restless leg syndrome. 
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Focused Topics and Evidence-Based Findings 
The BARS scale is centered around akathisia symptoms. It is an easy tool to add 
to an initial assessment to get a baseline of akathisia symptoms. An AIMS scale 
exclusively measures tardive dyskinesia. Although an AIMS scale asks a few questions 
that pertain to abnormal movement in the extremities, this does not suffice for a 
commonly overlooked symptom like akathisia. According to Hirose, there are two major 
reasons why akathisia may be overlooked and underdiagnosed (2003). The first reason is 
the inability to fulfill diagnostic criteria for akathisia and the second reason is conditions 
that do not fulfill diagnostic criteria but can still benefit from anti-akathisia interventions 
that are underdiagnosed (Hirose, 2003).  Clinicians are less worried about akathisia since 
atypical anti-psychotics are said to produce fewer extrapyramidal side effects (EPS) 
(Hirose, 2003). Akathisia and other EPS side effects still exist with the use of atypical 
anti-psychotics. Literature notes that of the six anti-psychotics available for prescription, 
risperidone and olanzapine are the two that show lower signs of EPS. These symptoms 
can worsen when the doses are increased (Farah, 2013).  Farah notes that the biggest 
concern with akathisia comes from the atypical anti-psychotic, aripiprazole (Farah, 
2013).  It is noted that most akathisia patients do not volunteer the information of inner 
restlessness until the term is explained to them. Motor restlessness is objectively seen and 
can be rated as such, but inner restlessness is subjective, and the patient would need to be 
questioned by the clinician for confirmation (Hirose, 2003).  
Rationale-Framework, Models, Concepts/Theories 
The problem persists that akathisia is a distressing side effect of anti-psychotic 
use that can lead to thoughts of suicide and non-compliance with medication. If clinicians 
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assess akathisia symptoms early on, this problem can be addressed and eliminated. The 
way to eliminate this problem is to add an akathisia scale to the initial mental health 
assessment and future mental health assessments. The AIMS score is captured on the 
initial mental health visit. The AIMS scale measures for EPS symptoms like tardive 
dyskinesia, not exclusively akathisia. The AIMS score may mask the true rating of 
akathisia. If the BARS scale was present to assess and rate akathisia, patients’ symptoms 
would be detected and treated sooner which will eliminate the distressing feeling patients 
have and eliminate or decrease suicidal thoughts related to impending restlessness related 
to akathisia. 
Summary 
In summary, akathisia is a reversible movement disorder that when diagnosed 
early can save the patient from having feelings of irritability, distress, and suicidal 
thoughts (Salem et al., 2017). Early diagnosis will also aid in medication compliance. 
Akathisia is one of the most common side-effects of antipsychotic medications and can 
easily be passed off as agitation when presented to a clinician unfamiliar with the 
disorder (Salem et al., 2017). The BARS scale is an easy rating scale used to measure 
akathisia. The scale is short, which is a great incentive to clinicians that are often on a 
time restraint. The use of the BARS scale is an easy effective addition to the patients’ 
assessment. The BARS scale is an asset to patients’ healthcare and well-being when anti-
psychotics are started, or anti-psychotic doses are increased. The BARS scale is an easy 
tool to measure a change in the patient leading to the detection of akathisia. Chapter I 
provided the introduction, background, and significance, project purpose, objective and 
expected outcomes, theoretical framework, needs assessment, synthesis of evidence, 
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focused topics and evidenced-based findings, and rationale framework. Chapter II will 






CHAPTER II – METHODS 
The purpose of this Doctor of Nursing Practice (DNP) project was to bring 
awareness to akathisia and the Barnes Akathisia Rating Scale (BARS). The use of the 
BARS scale would accurately measure akathisia and offer a numerical value that would 
range from 0-9. Zero would be no signs of akathisia and the number nine would indicate 
severe akathisia. This scale would be used at the start of any anti-psychotic medication 
treatment and would also be used at follow-up visits. The use of the BARS scale 
ultimately improves the accuracy of the patient’s akathisia symptoms. The BARS scale 
offers transparency in the level/rate of the patient presenting with akathisia. 
Setting 
The DNP Project was conducted in a southern behavioral health Mississippi clinic 
located in Poplarville, Mississippi. The clinic sees more than four hundred patients in a 
30-day span. The clinic is staffed by two nurse practitioners and two nurses. The 
outpatient clinic sees a host of patients beginning at the age of five years old and across 
the lifespan. The outpatient clinic provides integrated mental health and behavioral health 
services. The number of patients experiencing akathisia in this clinic presented a great 
opportunity to offer information about akathisia and an akathisia rating scale.  
Population/Sampling 
The population of interest consists of mental health patients with schizophrenia 
diagnoses. The population included patients ages 18-64. Each of these patients were 
prescribed anti-psychotic medication. The study excluded adolescent and geriatric 
patients. Out of the four hundred thirty-six (436) patients seen in a thirty (30) day span, 
twenty-seven (27) patients of those patients experienced akathisia.  
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Data Collection, Procedures, and Design 
A scenario-based case study focused on the literature was performed to classify 
trials of atypical anti-psychotics affecting patients ages 18-64 with schizophrenia or 
associated conditions (e.g., schizoaffective disorder). The project involved randomized 
scenario-based case studies. The scenario-based case study included four detailed 
questions related to akathisia presentation in a clinical setting. Data on the evolving 
BARS akathisia scale were included. A pre-test was provided to the clinical staff. After 
the pre-test, the staff was educated on akathisia and its presentation, along with being 
educated on the BARS scale. A post-test was given. The test provided to participants 
determined the integrity and validity of the BARS scale. All consents and data collection 
were exchanged through a secure email. Most participants chose to print their emails and 
hand score each question, while other participants chose to digitally answer their 
questions. Each email was sent separately and privately. 
Ethical Considerations 
This project was submitted to The University of Southern Mississippi IRB 
(Protocol # 21-204) for approval. This project did not include the study of any human 
subjects; therefore, there were no direct violations of ethical principles. The sole purpose 
of this project was to bring awareness to akathisia and implement an akathisia rating 
scale.  
Data Analysis 
Data from this project included a pre-test, which tested the knowledge of the topic 
with the participants involved. The pre-test included questions about how the participants 
narrate their patients' side effects to antipsychotics. The participants were then educated 
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on the topic and its’ purpose. The education was given to participants in the form of a 
PowerPoint®. A post-test was given. The participants' post-test results were compared. 
Scores were analyzed using simple mathematical addition.  
Summary 
After the completion of the project, the test was scored in a secure private room 
by the doctoral student. Each test was carefully read and measured by the doctoral 
student. The results of the post-test were discussed with the nurses and nurse 
practitioners. The data was protected and remained safely stored. The results are 






CHAPTER III  - RESULTS 
The doctoral project met its goal of implementing and integrating the Barnes 
Akathisia Rating Scale into the mental health assessment. The participants agreed that the 
BARS scale was a more accurate tool to measure akathisia. This doctoral project also 
improved the knowledge of akathisia symptoms among the nurses working at this clinic. 
The nurse practitioners encouraged the use of the BARS scale as a baseline to measure 
for akathisia symptoms, and as a tool to use throughout the treatment of antipsychotic 
use.  
Analysis of Data 
A secure email was used for participants. In this email, participants were given an 
invitation to participate in the DNP project. In addition to the initial invitation, consent to 
participate in the DNP project was given as well. The participants had to sign the consent 
form and email the consent back to the secure email address. The participants were given 
a pre-test. The pre-test tested the participant's knowledge of akathisia, tardive dyskinesia, 
and their presentation. A question related to the BARS scale was also included in the pre-
test. The pre-test was given through a secure email and sent back through secure email. 
Education was provided via PowerPoint® and sent through secure email. Participants 
were given five days to review the education provided on akathisia and the Barnes 
Akathisia Rating Scale. After the five days, a post-test was given. The post-test was a 
scenario-based clinical study given to participants.  The post-test provided included a 
total of four scenario-based questions. These questions were sent along with the Barnes 
Akathisia Rating Scale. The scale ensured that all participants had all resources needed to 
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accurately rate their patient’s severity of akathisia. Participants were to read each 
question and rate the level of severity for each scenario-based patient. 
Results took a week to come in. There were two occasions where there was data 
missing. Two participants did not read the directions carefully and did not use the BARS 
scale as directed. These participants were encouraged to re-read the directions and re-take 
their post-test using the BARS scale and resend their results via the secure email. 
Participants were compliant with resending emails and using the BARS scale to rate the 
severity of akathisia.  
Results of the pretest revealed that 60% of participants see akathisia on a weekly 
basis. All participants knew what akathisia was, most explained akathisia in a note while 
20% used AIMS to measure akathisia. The post-test revealed 80% of participants 
answered the questions similarly. The post-test proves that the BARS scale is a valid tool 
that can be used to accurately measure and rate the level of severity for akathisia.  
 




Figure 2. Percentage of Participants that See Akathisia on a Weekly Basis. 
 
 





The comparison of post-test results revealed that the Barnes Akathisia Rating 
Scale (BARS) is an accurate tool. The tool measures akathisia because most participants 
answered their scenario-based questions the same. This proves that the measuring tool is 






CHAPTER IV – DISCUSSION 
Through implementing an akathisia scale into the mental health assessment, the 
akathisia scale offered a baseline of the patients’ level of severity of akathisia. The 
participants in the study mostly rated the scenario-based patient questionnaire similarly. 
These scores indicated that the use of the BARS scale would be successful and offer 
depth and accuracy to the patients’ diagnosis and treatment plan. Results revealed four 
out of five participants answered the scenario-based questions similarly. Participants 
rating their patient scenarios similarly prove that the BARS scale is effective in rating 
akathisia. Offering a baseline of akathisia symptoms can be difficult. Proper education of 
the BARS scale and its’ use can allow for transparent symptoms of akathisia between 
follow-up visits and/or change in healthcare providers. Healthcare providers agreed that 
this addition to their assessment would offer an easier and accurate way to share data on 
patients exhibiting akathisia.  
Akathisia is one of the most distressing symptoms associated with antipsychotic 
medication use. Some patients state the feeling of akathisia is an indescribable feeling 
they cannot control. Those patients experiencing akathisia, experience an inability to sit 
still and a constant urge to move (Salem et al., 2017). The feeling of inner restlessness 
causes the patient to rock while standing or sitting and to constantly move their feet. 
Unlike tardive dyskinesia, akathisia mostly deals with lower extremity movement. 
Tardive dyskinesia can affect the orofacial muscles, hands, and feet. Akathisia and 
tardive dyskinesia are both EPS symptoms, these two side effects are so common. 
Different scales should be used to measure akathisia and tardive dyskinesia. With the use 
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of different rating scales for akathisia and tardive dyskinesia, there will be no confusion 
in the level of severity for each.  
Healthcare Professional Role Change (HCP) and Future Role Implications 
The author’s role as a healthcare provider changed from being a bedside nurse 
and student to making decisions that can alter medication doses, rendering a new 
prescription, or decrease/increase in medication. It takes skill and expertise to write 
prescriptions. As an aspiring PMNP (psychiatric mental health nurse practitioner), a 
combination of higher education and hands-on clinical learning has eased the anxiety of 
transitioning quite a bit. Many PMNP has similar responsibilities as a psychiatrist. 
Diagnosing, treating, and prescribing psychotropic medications are all a part of treating 
mental health patients. The author has grown comfortable in her current role as a staff RN 
(registered nurse). She has mastered the daily tasks of nursing and has developed 
observation skills as well as the skill to act on instinct. The author currently works 
twelve-hour shifts three days a week. A Monday through Friday job as a PMHNP in an 
outpatient setting will be a significant change. Sitting, talking, and listening to patients in 
a clinical setting for a fifteen-minute interval is a difficult task. The fifteen-minute 
intervals will include charting and prescribing as well. The author’s goal is to provide the 
best care for every patient all while being an efficient and productive provider.  
Interpretation 
The BARS scale was used in the implementation of this DNP project because it 
helps rate the level of severity of akathisia symptoms. The impact this project has on the 
mental health population is great. This project brings awareness to the way akathisia is 
documented. The BARS scale allows for accurate measurement of akathisia without 
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masking the symptoms. Akathisia can be easily missed or passed off as irritability or 
even misdiagnosed as restless leg syndrome. Most results from this DNP study were 
answered similarly. Four out of five participants had the same answers. Outcomes may 
have been different because the participant may have misread the instructions. Before 
starting this project participants were charting a narrative note to describe the patients’ 
symptoms. Other providers were using the AIMS scale to measure akathisia symptoms. 
Using the BARS scale offers transparency to the level of severity of the patient's 
symptoms, focusing on akathisia and no other symptom or side effect. In narrative notes, 
a way of wording may be confusing or misinterpreted. With the use of the AIMS scale 
akathisia symptoms can be masked as well due to other questions that pertain to tardive 
dyskinesia. Through the use of the BARS scale the level of severity of akathisia is more 
precise. The scale offers a range in severity of akathisia symptoms. If the results of this 
project were compared to the results of the Turkish BARS project, it would be 
comparable. The Turkish BARS project shows high reliability to the use of the BARS 
akathisia scale (Bayram et al., 2017). Through the use of the BARS scale patients’ 
akathisia symptoms can be rated easily according to their level of severity. By bringing 
awareness to the BARS scale and its purpose, healthcare providers can measure akathisia 
symptoms earlier and throughout treatment. Patients will experience shorter periods of 
distress with the use of the BARS scale, which will aid in medication compliance 
ultimately stabilizing the patients’ mental health.  
Limitations and Barriers 
Limitations to this DNP study included sample size and limitation on using one 
facility. If there were more participants, the outcomes may have differed. If an additional 
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clinic could have been used to compare patients seen with akathisia, the need for an 
akathisia scale may have differed. In other clinic’s there may have been some form of an 
akathisia rating scale used that was not incorporated in the clinic where this DNP project 
was performed. Many things exist that could have altered the study. Some bias that may 
present may relate to using the AIMS scale to measure akathisia.  The author firmly 
believes that the AIMS scale masks akathisia symptoms. The AIMS scale particularly 
favors tardive dyskinesia. The two abnormal movements are very different in 
characterization and should be rated separately on different forms of abnormal movement 
scales.  
Barriers to this study include time constraints and how long the author could hold 
the participants' attention with this project. The author had to remind each participant to 
answer their email in a timely fashion. Some participants were eager to finish while other 
participants needed constant reminders to do so. Other barriers included the inability to 
control the participants from searching for data on akathisia during the pretest time frame. 
One participant included that they searched for information to answer one of the 
questions, which was prohibited.  
Conclusions 
At the end of this project, participants appreciated the information given on 
akathisia and the BARS scale. Participants felt that the BARS scale was much more 
relatable to akathisia than the AIMS scale. Akathisia is a known side effect of 
antipsychotics, yet participants did not know to which extent patients were suffering. All 
participants involved in this project agreed that the BARS scale can easily be 
incorporated into each mental health assessment of a patient being started on an 
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antipsychotic. Participants also agreed the BARS scale is a great tool to use to measure 
akathisia throughout antipsychotic medication treatment. 
The sustainability of this project is great in comparison to the Turkish akathisia 
project. The conclusion of the DNP project ended with great percentages. Everyone that 
participated in the project had similar answers, which proves that the BARS scale is easy 
to learn and incorporate in mental health assessments. With such a large percentage of 
participants answering the questions similarly, it makes the project impactful and easily 
understood. The goal of incorporating the BARS scale was to impact health care without 
making it a nuisance to incorporate another document into the mental health assessment. 
The BARS scale is an asset. Detecting akathisia at its’ earliest stages before it becomes 
debilitating to the patient is the priority.  
The BARS scale will be incorporated into the mental health assessments of 
patients taking anti-psychotics. The author will share the information about the BARS 
scale with those she works with through verbal conversation and handouts. Through 
discussion, the author will explain to other providers that while researching an akathisia 
rating scale that providers caring for patients with akathisia did not know the extent to 
which their patients were suffering. The feeling of internal restlessness leads some 
patients to have thoughts of suicide. The uncomfortable feeling akathisia induces is a 
huge dilemma that has gone overlooked for too long. Providers need to be aware of the 
extent of the mental debilitating factors that can take place with the use of antipsychotics.  
If anything could be done differently in this project, it would be to create a new 
akathisia scale, incorporating more subjective data questions for the patient. One that 
would probably be like the BARS scale with more descriptive symptoms and side effect 
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choices. More time could have been spent with the participants, but participants' 
schedules were conflicting. An in-person educational presentation on akathisia would 
have been ideal, but due to covid, the author felt a contactless free presentation would be 












APPENDIX B – Barnes Akathisia Rate Scale 
Name:________________________________________               Date:__________________  
  
Instructions: Patients should be observed while they are seated, and then standing while 
engaged in neutral conversation (for a minimum of two minutes in each position).  Symptoms 
observed in other situations, for example, while engaged in activity on the ward, may also be 
rated.  Subsequently, the subjective phenomena should be elicited by direct questioning.    
  
Objective  
 Normal, occasional fidgety movements of the limbs  
0 Presence of characteristic restless movements:  shuffling or tramping movements of the 
legs/feet, or swinging of one leg while sitting, and/or rocking from foot to foot or 
“walking on the spot” when standing, but movements present for less than half the time 
observed  
1 Observed phenomena, as described in (1) above, which are present for at least half the 
observation period  
2 The patient is constantly engaged in characteristic restless movements, and/or cannot 
remain seated or standing without walking or pacing, during the time observed  
  
Subjective  
 Awareness of restlessness  
0 Absence of inner restlessness  
1 Non-specific sense of inner restlessness  
2 The patient is aware of an inability to keep the legs still, or a desire to move the legs, 
and/or complains of inner restlessness aggravated specifically by being required to a 
standstill  
3 Awareness of intense compulsion to move most of the time and/or reports strong desire 
to walk or pace most of the time  
  
Distress related to restlessness  
0 No distress  
1 Mild  
2 Moderate  
3 Severe  
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Global Clinical Assessment of Akathisia 
  
0 Absent.  No evidence of awareness of restlessness.  Observation of characteristic 
movements of   akathisia in the absence of a subjective report of inner restlessness or 
compulsive desire to move the legs should be classified as pseudoakathisia  
1 Questionable.  Non-specific inner tension and fidgety movements  
2 Mild akathisia.  Awareness of restlessness in the legs and/or inner restlessness is worse 
when required to stand still.  Fidgety movements are present, but characteristic restless 
movements of akathisia are not necessarily observed.  The condition causes little or no 
distress.    
3 Moderate akathisia.  Awareness of restlessness as described for mild akathisia above, 
combined with characteristic restless movements such as rocking from foot to foot when 
standing.  A patient finds the condition distressing  
4 Marked akathisia.  The subjective experience of restlessness includes a compulsive desire 
to walk or pace.  However, the patient can remain seated for at least five minutes.  The 
condition is obviously distressing.    
5 Severe akathisia.  The patient reports a strong compulsion to pace up and down most of 
the time. Unable to sit or lie down for more than a few minutes.  Constant restlessness is 
associated with intense distress and insomnia.    
  
  
Scoring the Barnes Akathisia Rating Scale (BARS)  
  
  
 The Barnes Akathisia Rating Scale is scored as follows:  
  
 Objective Akathisia, Subjective Awareness of Restlessness, and Subjective Distress 
Related to Restlessness are rated on a 4-point scale from 0 – 3 and are summed yielding a 
total score ranging from 0 to 9.    
  
 The Global Clinical Assessment of Akathisia uses a 5-point scale ranging from 0 – 4.    
  
  
(Barnes, 1989, pp. 672-767). 
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APPENDIX C – Akathisia Survey 
This study has been approved by USM’s IRB.  
Protocol number: XXX 
 
You are Invited to Participate 
Hello everyone,  
My name is Heather Thompson RN, BSN I am a DNP student at The University 
of Southern Mississippi. I am doing an evidence-based practice research intervention. My 
intervention will include a scenario-based pretest, education on an akathisia scale, and a 
scenario-based post-test.  
 
Purpose: The purpose of my project is to bring awareness to akathisia and the 
need for an akathisia rating scale. This allows for easy communication of akathisia 
symptoms between providers. The scale brings accuracy to the level of severity of 
akathisia symptoms before and during treatment.   
 
Description of Study: The study will include healthcare providers at a 
Southeastern Mississippi Behavioral Clinic. The providers will be given a scenario-based 
case study to test their knowledge of akathisia and the way they narrate their akathisia 
findings. Next, the healthcare providers will be educated on akathisia and a rating scale 
that will offer a baseline numerical scale for akathisia. A scenario-based case study will 
be given as a post-test to implement the akath2isia rating scale and test the knowledge of 
the staff.   
 
Benefits: Healthcare providers will benefit from awareness of akathisia and its 
scale by having the ability to detect and rate akathisia accurately. This will lead to early 
detection and treatment. The akathisia scale will offer transparency of akathisia 
symptoms between visits. The level of severity of akathisia symptoms will be 
straightforward and to the point.  
 





1. Do you recognize the physical symptoms of akathisia?  
 a. How do you document your findings of akathisia symptoms?  
 2. Do you know what a BARS (Barnes Akathisia Rating Scale) scale are?  
 3. How is akathisia evaluated in current patients?  
4. How do you measure the impact of treatment from a visit to a visit?  




APPENDIX D – Scenario-Based Questionnaire Using the Barnes Akathisia Rating Scale 
Scenario #1 
 
A 35-year-old female comes into the office. She is taking Zyprexa 10mg daily. 
The patient walks with a steady gait, when the patient stops walking patients’ feet 
continue to move in a mild stepping manner. Upon sitting the patient has involuntary 
shaking of the lower extremities. The patient states, “I noticed my leg shaking when I sit 
but I did not think much of it, I feel fine.” The patient appears to have mild involuntary 
leg tremors. How would you explain this patient’s condition and rate the level of severity 




A 20-year-old male has started taking clozapine 12.5mg daily. At the patient's 
next visit clozapine dose was increased to 25mg. Over the next few weeks, the patient's 
dose gradually increased to 100mg. The patient reports, “I feel restless, I want to relax 
but I can’t.” The healthcare provider has the patient rate the severity of their symptoms 
on a scale of 1-10.  One being nearly no symptoms at all and ten being unbearable 
symptoms. The patient states, “If this does not stop, I will not continue taking clozapine. I 
rate this feeling of restlessness as an 8/10.” The patient has facial grimacing and appears 
irritable. What would you rate the patient’s akathisia score on the Barnes Akathisia 




A 45- year-old female taking Vraylar 1.5mg daily. Upon taking a seat in the 
provider’s office the patient appears uncomfortable, with a mild right leg tremor. The 
patient reports, “I feel fine, my leg tremor doesn’t bother me, the medication is working 
great.” The patient rates her leg tremor on a scale of 1-10 in severity as a 3. How would 





 A 33-year-old-male presents to his doctor’s visit with feelings of increased 
agitation and irritability. The patient’s current medication is Abilify 10mg daily, and 
Clonidine 0.2mg nightly. The patient reports sleeping well but has a mild foot tremor 
during the night that worsens when he awakens. The patient states, the tremors are 
bothering him so much so that he would like medication to help him fix this problem. 





APPENDIX E – Implementation of an Akathisia Scale into the Initial Mental Health 
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